How the removal of macrophages from tissue can stop or slow down the progression of CLL
Highlights from EHA 2016 press briefings: POLLUX and EURO-SKI trials and BiTE antibodies
Why is personalized medicine important for CLL?
Therapeutic monoclonal antibodies for multiple myeloma
Highlights from the International Symposium on Acute Leukemias (ISAL) 2017 in Munich